Combined modality treatment with “dexamethasone, methotrexate, ifosfamide, l-asparaginase, and etoposide” chemotherapy and involved field radiotherapy for early stage natural Killer/T cell lymphoma with local tumor invasiveness: A single-institution study from India

Combined modality treatment with “dexamethasone, methotrexate, ifosfamide, l-asparaginase, and etoposide” chemotherapy and involved field radiotherapy for early stage natural Killer/T cell lymphoma with local tumor invasiveness: A single-institution study from India

Context: Patients with early stage extranodal natural killer/T-cell lymphoma, nasal type (ES-NKTCL) and local tumor invasiveness (LTI) show poor treatment outcomes with standard approaches. Dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) is an intensive, highly active...

Full description

Saved in:
Bibliographic Details
Main Authors: Vineet G Gupta, Ajay Gogia, Lalit Kumar, Atul Sharma, Sameer Bakhshi, Mehar C Sharma, Saumyaranjan Mallick, Ahitagni Biswas, Prashant Mehta, Sanjay Thulkar, Ranjit K Sahoo, Rakesh Kumar
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2018-01-01
Series:Indian Journal of Medical and Paediatric Oncology
Subjects:
Asparaginase
chemotherapy
lymphoma
methotrexate
natural killer cells
Online Access:http://www.ijmpo.org/article.asp?issn=0971-5851;year=2018;volume=39;issue=1;spage=67;epage=72;aulast=Gupta
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items